MSU crystals then activate monocytes and macrophages, resulting in the NLRP3 (NLR family pyrin domain containing 3) inflammasome-mediated release of IL-1B and proinflammatory cytokines and recruitment of neutrophils to the site of crystal deposition, driving the clinical features of gout [47]. This evidence concerns the gene NLRP3 and gout.